Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/02/2003US20030187055 Synergistic pharmaceutical combinations for treating obesity
10/02/2003US20030187028 Synergistic mixtures; side effect reduction
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187018 Viricides; immunomoderators
10/02/2003US20030186960 Nervous system regeneration
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186921 Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
10/02/2003US20030186920 Target genes and mRNAs encoding mammalian vascular endothelial growth factor(VEGF) receptors can be used to reduce VEGF-induced inflammation and angiogenesis; for treatmment of tumor growth and metastasis, ocular diseases, arthritis
10/02/2003US20030186915 Derived from regulatory region of secondary osteoporosis gene; use of such polynucleotides for screening for agents that affect osteoporosis regulation, for tissue-specific gene expression, and other therapeutic and diagnostic applications
10/02/2003US20030186910 Anticarcinogenic agents
10/02/2003US20030186909 Nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
10/02/2003US20030186907 Endometrial function
10/02/2003US20030186906 Mixture comprising an inhibitor or suppresor of a gene and a molecule binding to an expression product of that gene
10/02/2003US20030186905 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone3' -untranslated region
10/02/2003US20030186904 Keratinocyte growth factor-2
10/02/2003US20030186903 Antisense modulation of MyD88 expression
10/02/2003US20030186902 Use of a pituitary tumor transforming gene peptide which has the ability to regulate endogenous PTTG1 expression and/or function in a dominant negative manner
10/02/2003US20030186897 Derivatives of branched-chain lipophilic molecules and uses thereof
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186895 Peptide mimetics used as RNA virus protease inhibitors, for prophylaxis of hepatitis virus infections
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186893 Purified lh
10/02/2003US20030186892 Enhancement of endogenous gonadotropin production
10/02/2003US20030186891 Polypeptide comprising fragments of matrix extracellular phosphoglycoproteins used to control calcitriol concentrations in cells, for prophylaxis of bone disorders
10/02/2003US20030186890 Amphipathic linear peptides and formulations containing said peptides
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186888 Diastereo analog of peptide SPFK-amide with selective anti-microbial activity and a method thereof
10/02/2003US20030186886 Administering polypeptides to eyes, for prophylaxis of vision defects
10/02/2003US20030186885 Soluble polypeptides comprising extracellular domains or variable peptides of blood coagulation factors, used for immunotherapy or for prophylaxis of thrombosis and cardiovascular disorders
10/02/2003US20030186884 Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions
10/02/2003US20030186883 Glycoprotein mimetics having ability for potentiation of thrombin-mediated activation of protein C and inability to activate thrombin-activatable fibrinolysis inhibitor (TAFI), used as anticoagulants
10/02/2003US20030186882 Methods and compositions for treating and preventing distal bowel lesions
10/02/2003US20030186881 Nucleotide sequences comprising complementary DNA codes for cyclin-dependent kinases, that control phosphorylation in cells, used in diagnosis and prophylaxis of diseases
10/02/2003US20030186880 Combination therapy using trefoil peptides
10/02/2003US20030186878 Human longevity assurance protein, its coding sequence and their use
10/02/2003US20030186877 Helical peptidomimetics
10/02/2003US20030186876 IL-6 antagonist peptides
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186874 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
10/02/2003US20030186872 Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
10/02/2003US20030186870 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
10/02/2003US20030186868 Useful to control pathological angiogenesis, such as occurs in cancer and other diseases
10/02/2003US20030186867 Using Corticotropin-releasing factor (CRF) receptor agonist, or a pharmaceutically acceptable salt, complex or prodrug thereof, for the manufacture of a medicament for the prevention or inhibition of neuronal cell death in a mammal
10/02/2003US20030186866 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
10/02/2003US20030186865 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
10/02/2003US20030186864 Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit I
10/02/2003US20030186863 For production of peptidomimetic drugs that modulate a large class of proteins involved in signal transduction pathways and oncogenesis
10/02/2003US20030186862 Used to increase clot formation in a mammal
10/02/2003US20030186861 HAUSP-p53 interaction and uses thereof
10/02/2003US20030186860 For therapy of Central Nervous System (CNS) disorders such as seizures and strokes, cognitive disorders, and for memory enhancement
10/02/2003US20030186859 58224, a novel helicase family member and uses therefor
10/02/2003US20030186858 Crystallisation of a GLP-1 analogue
10/02/2003US20030186857 Use of 3-position cyclosporin derivatives for hair growth
10/02/2003US20030186856 Process for the isolation of pharmaceutical compound cyclosporin a from fungus fusarium nivale
10/02/2003US20030186855 Systemically administering cyclic peptide compound, salt, ester or prodrug for reducing toxicity associated with the administration of cyclosporin A
10/02/2003US20030186854 Having low hemolytic activity, antiparasitic, antifungal and antibacterial activities
10/02/2003US20030186853 For therapy of proliferative disorders of the skin and other tissues
10/02/2003US20030186852 Compositions and methods for controlling plant pests
10/02/2003US20030186851 Binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium
10/02/2003US20030186850 Administering an effective amount of an appropriate agent which is effective in modulating functions of one or more polypeptide GalNAc-transferases (N-acetylgalactosaminyltransferases)
10/02/2003US20030186849 Modified peptides and their use for the treatment of autoimmune diseases
10/02/2003US20030186847 Insulin derivatives and synthesis thereof
10/02/2003US20030186846 Novel glucose-dependent insulins
10/02/2003US20030186845 Compositions for preventing urinary calculus
10/02/2003US20030186844 Gherlin analogs
10/02/2003US20030186843 Powder comprising active material and further comprising an indicator material that is capable of indicating to a patient that a dose of the active material has been administered
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186841 Ligand activated transcriptional regulator proteins
10/02/2003US20030186839 Medicinal compositions
10/02/2003US20030186436 Insulin-secreting cell which codes and expresses glucagon-like peptides-1 (GLP-1) for treating diabetes and autoimmune diseases
10/02/2003US20030186435 Comprises antagonist that inhibits activity or expression oxidoreductase (FABH) for treating bacterial infection; bactericides
10/02/2003US20030186433 Novel fibroblast growth factor and nucleic acids encoding same
10/02/2003US20030186422 Methods for the treatment of thrombosis
10/02/2003US20030186421 Comprises lipoprotein associated phospholipase A2 (Lp-PLA2) for diagnosing and treating atherosclerosis; enzyme inhibitors
10/02/2003US20030186419 Masp-3, a complement-fixing enzyme, and uses for it
10/02/2003US20030186416 Coding sequence for protein phosphatase methylesterase, recombinant DNA molecules and methods
10/02/2003US20030186415 Mutant possessing uracil phosphoribosyl transferase activity
10/02/2003US20030186409 Extracting enzyme inhibitors from wheat flour or gluten for treating hyperglycemia, diabetes, hyperlipemia and arteriosclerosis
10/02/2003US20030186408 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186407 Comprises membrane protein for use as antitumor/antiproliferative/antiinflammatory/anticarcinogenic agents
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186387 Comprises nucleotide sequences coding cytokines for use in treatment and diagnosis of autoimmune disorders
10/02/2003US20030186386 Interleukin 10
10/02/2003US20030186385 Method of identifying polypeptide monobodies which bind to target proteins and use thereof
10/02/2003US20030186383 Comprise nucleotide sequences coding growth factor polypeptide for diagnosing and treating autoimmune, cell proliferative, atherosclerotic, inflammatory and cancer disorders; tissue engineering; wound healing agents
10/02/2003US20030186382 Angiogenesis inhibiting peptide for diagnosing diseases of human pregnancy which involve aberrations of placental vascularization
10/02/2003US20030186377 Comprises nucleotide sequences coding transcription factor for treating infections, multiple sclerosis, arthritis and autoimmune disease
10/02/2003US20030186371 Comprise sequences coding protein related to human leukocyte antigen-C (HLA-C) for diagnosis and treatment of skin disorders; animal models
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186365 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186360 Comprises nucleotide sequences coding membrane protein for use in diagnosis and treatment of disorders of colon, urogenital and autoimmune systems
10/02/2003US20030186358 Comprise nucleotide sequences coding membrane protein for use as antitumor, antiproliferative, anticarcinogenic or antiinflammatory agents
10/02/2003US20030186357 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
10/02/2003US20030186337 Novel death associated proteins, and THAP1 and PAR4 pathways in apoptosis control
10/02/2003US20030186333 Comprises nervous system polypeptide for diagnosis, prognosis, treatment and evaluation of neurodegenerative disorders
10/02/2003US20030186332 CompriseS nucleotide sequences coding neurotrophic factor expression-inducing agent (PSEC56 protein) for designing therapies for treating nervous system disorders
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186321 Comprises polypeptide having antitumor, immunomodulatory and viricidal activity for treating leukemia, hepatitis and autoimmune diseases
1 ... 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 1771 1772 1773 1774 1775 1776 1777 1778 1779 ... 3163